GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pacific Edge Ltd (OTCPK:PFGTF) » Definitions » COGS-to-Revenue

Pacific Edge (Pacific Edge) COGS-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pacific Edge COGS-to-Revenue?

Pacific Edge's Cost of Goods Sold for the six months ended in Mar. 2024 was $0.00 Mil. Its Revenue for the six months ended in Mar. 2024 was $6.58 Mil.

Pacific Edge's COGS to Revenue for the six months ended in Mar. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Pacific Edge's Gross Margin % for the six months ended in Mar. 2024 was N/A%.


Pacific Edge COGS-to-Revenue Historical Data

The historical data trend for Pacific Edge's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Edge COGS-to-Revenue Chart

Pacific Edge Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pacific Edge Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pacific Edge COGS-to-Revenue Calculation

Pacific Edge's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 14.542
=0.00

Pacific Edge's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 6.577
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pacific Edge  (OTCPK:PFGTF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Pacific Edge's Gross Margin % for the six months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 6.577
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Pacific Edge COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pacific Edge's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Edge (Pacific Edge) Business Description

Traded in Other Exchanges
Address
87 St David Street, P.O. Box 56, Dunedin, STL, NZL, 9016
Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.

Pacific Edge (Pacific Edge) Headlines

From GuruFocus

Half Year 2023 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2021 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Half Year 2022 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2024 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Trading Halt Transcript

By GuruFocus Research 02-14-2024

Full Year 2022 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2023 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024